Global Search | Novartis

Hide Filters

Showing 2681 results

Biography / Aug 19, 2021

Ton Buechner
General Meetings
Biography / Mar 04, 2025

Giovanni Caforio
Biography / Mar 04, 2025

Elizabeth McNally
Biography / Mar 03, 2022

Ana de Pro Gonzalo
Key Release / Apr 03, 2025

Novartis receives FDA accelerated approval for Vanrafia® (atrasentan), the first and only selective endothelin A receptor antagonist for proteinuria reduction in primary IgA nephropathy (IgAN)

Ad hoc announcement pursuant to Art. 53 LR Vanrafia can be seamlessly added to supportive care in IgAN and used as a foundational therapy with no requirement for a REMS (Risk Evaluation…
ESG Index: Ethical business practices
ESG Index: Environmental sustainability
Human rights
Press Release / Mar 31, 2025

Novartis appoints Karen Hale, Chief Legal and Compliance Officer, as Klaus Moosmayer, Chief Ethics, Risk & Compliance Officer, steps down from the Executive Committee of Novartis

After nearly seven years as a member of the Executive Committee of Novartis (ECN), Klaus Moosmayer will pursue his next chapter of leadership outside of NovartisKaren Hale to drive the next phase of…